(Q58855786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sandro Cosconati

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Vittorio Limongelli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Ettore Novellino

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

540-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

Cell cycle regulation by the Cdc25 phosphatase family

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

The coordinated action of protein tyrosine phosphatases and kinases in cell signaling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Form and function in protein dephosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

The X-ray crystal structures of Yersinia tyrosine phosphatase with bound tungstate and nitrate. Mechanistic implications

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Molecular mechanisms of the protein serine/threonine phosphatases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

The structure and mechanism of protein phosphatases: insights into catalysis and regulation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

CDC25 phosphatases as potential human oncogenes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Cdc25 cell-cycle phosphatase as a target of c-myc

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Role of the Cdc25A phosphatase in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Rapid destruction of human Cdc25A in response to DNA damage

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Elevated expression of the cdc25A protein phosphatase in colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Cdc25 as a potential target of anticancer agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Crystal structure of the dual specificity protein phosphatase VHR

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Automated docking of flexible ligands: applications of AutoDock

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Development and validation of a genetic algorithm for flexible docking

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Comparative evaluation of 11 scoring functions for molecular docking

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Synthesis and antitumor activity of some new substituted quinolin-4-one and 1,7-naphthyridin-4-one analogs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

A novel synthetic inhibitor of CDC25 phosphatases: BN82002.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Structural mechanism of oxidative regulation of the phosphatase Cdc25B via an intramolecular disulfide bond

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Strategic approaches to drug design. I. An integrated software framework for molecular modelling.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500092

7 January 2021

Identifiers

DOI

10.1002/CMDC.200500092

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892390%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference